Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) shares dropped 8.5% on Wednesday. The stock traded as low as $6.93 and last traded at $6.9760. 353,114 shares were traded during trading, a decline of 94% from the average session volume of 5,574,933 shares. The stock had previously closed at $7.62.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on the company. The Goldman Sachs Group restated a “buy” rating and issued a $12.00 target price on shares of Alignment Healthcare in a research report on Thursday, October 22nd. UBS Group dropped their price target on Alignment Healthcare from $9.00 to $8.00 and set a “neutral” rating for the company in a research report on Friday, October 30th. KeyCorp downgraded Alignment Healthcare from an “overweight” rating to a “sector weight” rating in a research note on Friday, October 30th. Needham & Company LLC began coverage on Alignment Healthcare in a report on Wednesday, October 28th. They issued a “hold” rating on the stock. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $15.00 target price on shares of Alignment Healthcare in a research note on Friday, October 30th. Six analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Alignment Healthcare has an average rating of “Hold” and an average target price of $14.00.
Check Out Our Latest Stock Report on Alignment Healthcare
Alignment Healthcare Price Performance
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last issued its earnings results on Thursday, October 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.04). Alignment Healthcare had a return on equity of 12.46% and a net margin of 0.59%. The company had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.31 billion. During the same period in the prior year, the business earned $0.02 EPS. The firm’s quarterly revenue was up 36.7% on a year-over-year basis. On average, equities research analysts predict that Alignment Healthcare, Inc. will post -0.03 earnings per share for the current fiscal year.
Insider Activity
In other news, CEO John E. Kao sold 27,400 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $13.00, for a total transaction of $356,200.00. Following the completion of the sale, the chief executive officer owned 590,766 shares in the company, valued at $7,679,958. This trade represents a 4.43% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Joseph S. Konowiecki sold 4,930 shares of the company’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $7.20, for a total value of $35,496.00. Following the completion of the transaction, the executive vice president directly owned 1,075,375 shares in the company, valued at approximately $7,742,700. This trade represents a 0.46% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 768,897 shares of company stock valued at $9,541,746 in the last ninety days. 5.20% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Alignment Healthcare
Several institutional investors and hedge funds have recently modified their holdings of ALHC. PNC Financial Services Group Inc. raised its position in Alignment Healthcare by 9.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 11,445 shares of the company’s stock worth $202,000 after buying an additional 962 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Alignment Healthcare by 46.6% in the 2nd quarter. GAMMA Investing LLC now owns 3,368 shares of the company’s stock worth $80,000 after acquiring an additional 1,070 shares during the period. Versant Capital Management Inc lifted its stake in shares of Alignment Healthcare by 463.3% in the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock worth $33,000 after acquiring an additional 1,135 shares during the period. Benjamin Edwards Inc. boosted its holdings in shares of Alignment Healthcare by 2.7% in the third quarter. Benjamin Edwards Inc. now owns 51,551 shares of the company’s stock valued at $421,000 after acquiring an additional 1,351 shares in the last quarter. Finally, Nykredit A S purchased a new stake in shares of Alignment Healthcare in the second quarter valued at about $36,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.
Alignment Healthcare Company Profile
Alignment Healthcare, Inc. is a technology-enabled healthcare company focused primarily on serving older adults through Medicare Advantage plans. Its health plans, offered under the Alignment Health Plan name, combine insurance coverage with care coordination and support intended to address members’ medical and everyday health needs. The company uses a care model that includes personalized care teams, member support and technology to help coordinate services across providers. Its Medicare Advantage offerings include plan options such as HMO and PPO products, with availability and benefits varying by location.
Further Reading
- Five stocks we like better than Alignment Healthcare
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
